RespireRx Pharmaceuticals Inc (RSPI)

[haysaw]

Right. At least that was what Stoll told us. The negotiations were supposedly in progress when the FDA put a stop on the drug. I wonder too, was Stoll playing hardball (likely, because the stock was riding high at the time); were his hands full (probably so, with all the buzz); was he dreaming about the boatload of money he was about to retire on (no doubt)?

If he did get the deal signed before the hold, it could have changed everything. With a big player involved, they might have assisted with the costs associated with the animal study redo's, EM, etc. They may also have been able to exert some influence with the FDA on their ultimate decision regarding ADHD. But that's neither here nor there-- Stoll couldn't have envisioned how things were about to turn--we can't fault Stoll for the unfortunate timing (at least not without more info).

I do wonder, however, if Stoll adhered to acceptable/ethical business practices by not digging into the histo finding when it turned up in the animal (monkey?) data. That, as it happened, turned out to be the critical error which has stranded us in the desert. Is that water out there? Nope, that's a mirage (more dilution ahead).